PEB:ASX
Pacific Edge Ltd
A$0.22
0.00%
(0.00) 1D
Nov 20, 4:00:00 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEB...
Open
A$0.22
High
A$0.22
Low
A$0.22
Mkt. cap
329.16M
Avg. vol.
56.93K
Volume
68.00
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
Open
A$0.22
High
A$0.22
Low
A$0.22
Mkt. cap
329.16M
Avg. vol.
56.93K
Volume
68.00
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
News stories
From web sources and news partners
Traders Union
·
1 hour ago
VIX fear index hits highest level since April 2025 as S&P 500 plunges
Nacionale
·
5 hours ago
Is the stock market down for the year? Only the Nasdaq; the S&P 500 and Dow are barely up for 2026
FXStreet
·
10 hours ago
Dow Jones Industrial Average drops for a fifth day as AI rout widens
Big News Network.com
·
37 minutes ago
S&P 500 earnings growth projected to slow to 11% in 2027 as AI investment impulse peaks: Goldman Sachs
Profile
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia
About Pacific Edge Ltd
CEO-
Employees114
Founded2001
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitepacificedgedx.com